Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipo-Dox in Breast Cancer Brain Metastasis
NCT00465673Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2005
- Primary completion
- Jul 2009
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2005; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00465673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465673.